908 Devices (NASDAQ:MASS) Director Sells $105,961.50 in Stock

908 Devices Inc. (NASDAQ:MASS) Director Christopher Brown sold 15,030 shares of the stock in a transaction dated Wednesday, April 8th. The shares were sold at an average price of $7.05, for a total value of $105,961.50. Following the completion of the transaction, the director owned 970,529 shares in the company, valued at approximately $6,842,229.45. The trade was a 1.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Performance

MASS opened at $7.14 on Monday. 908 Devices Inc. has a one year low of $3.79 and a one year high of $9.34. The company has a market cap of $266.89 million, a P/E ratio of 12.98 and a beta of 0.54. The business’s 50-day simple moving average is $6.47 and its 200-day simple moving average is $6.66.

908 Devices (NASDAQ:MASS) last released its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. 908 Devices had a negative return on equity of 14.99% and a net margin of 34.68%.The business had revenue of $17.38 million for the quarter, compared to the consensus estimate of $16.19 million. As a group, analysts predict that 908 Devices Inc. will post -1.99 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MASS. Wall Street Zen upgraded 908 Devices from a “hold” rating to a “buy” rating in a report on Saturday, March 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of 908 Devices in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, 908 Devices currently has an average rating of “Hold” and a consensus target price of $12.00.

Key 908 Devices News

Here are the key news stories impacting 908 Devices this week:

• Neutral Sentiment: SVP Kevin J. McCallion sold 18,580 shares on April 8 at an average $7.05 (proceeds $130,989). The sale was executed under a Rule 10b5‑1 plan and left him with 44,925 shares. Form 4
• Neutral Sentiment: SVP Kevin J. McCallion sold an additional 5,420 shares on April 9 at an average $7.03 (proceeds ~$38.1k), also under a 10b5‑1 plan. He still holds 44,925 shares. Form 4
• Neutral Sentiment: Director Christopher D. Brown sold 17,578 shares on April 10 at $7.07 (proceeds ~$124.3k), under a 10b5‑1 plan; he remains a large holder (~945,559 shares). Form 4
• Neutral Sentiment: Director Christopher D. Brown sold 7,392 shares on April 9 at $7.04 (proceeds ~$52.0k), and 15,030 shares on April 8 at $7.05 (proceeds ~$106.0k); all under a 10b5‑1 plan. Form 4
• Neutral Sentiment: Reported short interest shows 0 shares (as of April 10), implying no measurable short pressure; the short‑interest ratio is effectively 0.0 days based on average volume. Source data flagged anomalous/NaN changes.
• Negative Sentiment: Combined impact: insiders sold ~64,000 shares this week for roughly $450k in proceeds. Even though sales were via 10b5‑1 plans (which mutes informational content), the concentrated volume of insider selling can create near‑term downward pressure or raise investor questions about insider liquidity needs.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Millennium Management LLC grew its stake in 908 Devices by 409.0% during the 4th quarter. Millennium Management LLC now owns 158,103 shares of the company’s stock worth $830,000 after buying an additional 127,040 shares during the last quarter. Engineers Gate Manager LP purchased a new position in 908 Devices during the 4th quarter worth approximately $140,000. Bridgeway Capital Management LLC grew its stake in 908 Devices by 65.6% during the 4th quarter. Bridgeway Capital Management LLC now owns 50,500 shares of the company’s stock worth $265,000 after buying an additional 20,000 shares during the last quarter. First Light Asset Management LLC grew its stake in 908 Devices by 92.6% during the 4th quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company’s stock worth $25,390,000 after buying an additional 2,325,690 shares during the last quarter. Finally, State of Wisconsin Investment Board purchased a new position in 908 Devices during the 4th quarter worth approximately $170,000. Hedge funds and other institutional investors own 88.06% of the company’s stock.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.